BAX855

pegylated recombinant factor VIII · Baxalta/Shire

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAX855, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A [Phase 3]

See pricing